Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Because the whole market is cooling off and there will be higher interest rates in the near future. That added to the fact it is out of reach of the bigger investors that normally stabilize prices it hits the share prices hard. I listened to Boris tonight on twitter. He is a clever guy and really tells it like it is. I did not used to have any interest here but after listening to how thoughtful he is and how he lays everything out, the good and the bad I have a new respect for him and his company. I think I will be rearranging some of my holdings. I am still kind of concerned about having to have operations in each individual state but he has a good vision for sure.
The Street isn’t going to move before legalization gets a fair vote.
It makes no sense how market is ignoring the fundamentals.
Until they get Safe Banking, which will allow for uplifting and institutional buying, there seems not to be enough retail buyers to absorb selling.
But why should there be heavy selling in the first place????
Agreed, though it helps to keep increasing the top and bottom lines.
Market does not seem to care. Seems they are looking for Safe Banking, otherwise they are not interested in industry
Curaleaf Opens Two New Pennsylvania Dispensaries
New locations in Greensburg and Wayne expand the Company's retail presence to 14 locations in one of the country's largest medical markets
WAKEFIELD, Mass., Jan. 20, 2022 /PRNewswire/ --Curaleaf Holdings, Inc. (CSE: CURA / OTCQX: CURLF) ("Curaleaf" or the "Company"), a leading international provider of consumer products in cannabis, today announced plans to open two new dispensaries in Pennsylvania. Curaleaf's latest locations in Greensburg and Wayne will increase the Company's retail footprint to 14 dispensaries statewide and 125 across the country. Two additional locations, Curaleaf Erie (7891 Peach St.) and Curaleaf State College (1248 S Atherton St.), are expected to open by the end of February, pending regulatory approval.
Curaleaf Greensburg, located at 5133 US-30, is the first of the dispensaries to hold a Grand Opening today, January 20. Curaleaf Wayne, located at 707 Lancaster Ave., has already undergone a soft opening and will celebrate its Grand Opening on Thursday, January 27. The Company's newest retail locations are dedicated to being a leading resource in research-based patient education and advocacy. Patients will have access to a selection of Curaleaf's top-selling vaporizer and whole flower products, including Select Elite, Select Elite Live, Grassroots Full-Spectrum RSOs, RSO capsules, prepackaged flower, distillate cartridges, strain-specific vape cartridges, as well as cured and live concentrates.
Since becoming a Clinical Registrant recognized by the Commonwealth's Department of Health in 2020, Curaleaf's Pennsylvania subsidiaries have supported research initiatives examining the potential benefits of cannabis by providing medical marijuana and guidance to patients. Curaleaf's first-in-the-nation research program builds upon the Company's ongoing efforts to provide clinically supported resources to Pennsylvania's over 681,000 registered patients.
"Curaleaf is proud to broaden its scope of patient care and provide premium medical marijuana products to our Greensburg and Wayne medical communities," said Chief Executive Officer Joe Bayern. "Our latest retail expansion allows us to further support patients in the state of Pennsylvania and work with esteemed scientists on essential medical marijuana studies that will empower both physicians and patients to make confident and informed decisions."
In addition to Curaleaf's latest two locations, the Company also serves patients through its Curaleaf dispensaries in Altoona, Bradford, Brookville, City Avenue, DuBois, Gettysburg, Harrisburg, Horsham, King of Prussia, Lebanon, Morton and Philadelphia. In the coming weeks, Curaleaf will offer grand opening discounts to veterans, seniors and first-time patients at all Pennsylvania locations. For more information on store openings, along with product offerings and hours of operation, please visit https://curaleaf.com/locations#pennsylvania.
About Curaleaf Holdings
Curaleaf Holdings, Inc. (CSE: CURA) (OTCQX: CURLF) ("Curaleaf") is a leading international provider of consumer products in cannabis with a mission to improve lives by providing clarity around cannabis and confidence around consumption. As a high-growth cannabis company known for quality, expertise and reliability, the Company and its brands, including Curaleaf and Select, provide industry-leading service, product selection and accessibility across the medical and adult-use markets. In the United States, Curaleaf currently operates in 23 states with 125 dispensaries, 25 cultivation sites, and employs over 5,200 team members. Curaleaf International is the largest vertically integrated cannabis company in Europe with a unique supply and distribution network throughout the European market, bringing together pioneering science and research with cutting-edge cultivation, extraction and production. Curaleaf is listed on the Canadian Securities Exchange under the symbol CURA and trades on the OTCQX market under the symbol CURLF. For more information, please visit https://ir.curaleaf.com.
Forward Looking Statements
This media advisory contains forward–looking statements and forward–looking information within the meaning of applicable securities laws. These statements relate to future events or future performance. All statements other than statements of historical fact may be forward–looking statements or information. Generally, forward-looking statements and information may be identified by the use of forward-looking terminology such as "plans", "expects" or, "proposed", "is expected", "intends", "anticipates", or "believes", or variations of such words and phrases, or by the use of words or phrases which state that certain actions, events or results may, could, would, or might occur or be achieved. More particularly and without limitation, this news release contains forward–looking statements and information concerning the opening of four new dispensaries in the state of Pennsylvania. Such forward-looking statements and information reflect management's current beliefs and are based on assumptions made by and information currently available to the company with respect to the matter described in this new release. Forward-looking statements involve risks and uncertainties, which are based on current expectations as of the date of this release and subject to known and unknown risks and uncertainties that could cause actual results to differ materially from those expressed or implied by such statements. Additional information about these assumptions and risks and uncertainties is contained under "Risk Factors and Uncertainties" in the Company's latest annual information form filed April 28, 2021, which is available under the Company's SEDAR profile at http://www.sedar.com, and in other filings that the Company has made and may make with applicable securities authorities in the future. Forward-looking statements contained herein are made only as to the date of this press release and we undertake no obligation to update or revise any forward-looking statements whether as a result of new information, future events or otherwise, except as required by law. We caution investors not to place considerable reliance on the forward looking statements contained in this press release. The Canadian Securities Exchange has not reviewed, approved or disapproved the content of this news release.
INVESTOR CONTACT
Curaleaf Holdings, Inc.
Carlos Madrazo, SVP Head of IR & Capital Market
IR@curaleaf.com
MEDIA CONTACT
Curaleaf Holdings, Inc.
Tracy Brady, VP Corporate Communications
media@curaleaf.com
SOURCE Curaleaf Holdings, Inc.
Curaleaf (OTCMKTS:CURLF) is now covered by analysts at Wolfe Research (star star star blank star blank star). They set a "peer perform" rating on the stock.
Has to stop at some point soon. When their assets are almost same as MC you would think the bottom is near.
I think this may end up fine when all MJ bills pass but for now it still seems to be in a death spiral as other stocks rising. :(
Something here just doesn't add up. Net income -56.92M 509.19%
Diluted EPS - -
Net profit margin -17.95% 250.59% down
CURALEAF ANNOUNCES $425 MILLION PRIVATE PLACEMENT OF 8% SENIOR SECURED NOTES DUE 2026
News Release Issued: Dec 13, 2021 (4:05pm EST)
To view this release online and get more information about Curaleaf Investor Relations visit: https://ir.curaleaf.com/2021-12-13-CURALEAF-ANNOUNCES-425-MILLION-PRIVATE-PLACEMENT-OF-8-SENIOR-SECURED-NOTES-DUE-2026
WAKEFIELD, Mass., Dec. 13, 2021 /PRNewswire/ -- Curaleaf Holdings, Inc. (CSE: CURA / OTCQX: CURLF) ("Curaleaf" or the "Company"), a leading international provider of consumer products in cannabis, today announced that it has received commitments for a private placement of 8.0% Senior Secured Notes due 2026 (the "Notes") for aggregate gross proceeds of US$425 million (the "Offering").
The Notes, which will be issued at 100% of face value, will be senior secured obligations of the Company and will bear interest at a rate of 8.0% per annum, payable semi-annually in equal installments until the maturity date, unless earlier redeemed or repurchased. The Notes will be governed by a trust indenture to be entered into on closing of the Offering (the "Indenture"). The Indenture enables the Company to issue additional notes on an ongoing basis as needed, subject to maintaining leverage ratios and complying with the other terms and conditions of the Indenture. In addition, the Indenture permits up to an additional US$200 million of senior bank financing. Curaleaf intends to use the net proceeds from the Offering to refinance existing indebtedness, for working capital, and to pay transaction fees and expenses. The Notes will mature on December 15, 2026. The Offering is expected to close on December 15, 2021, subject to customary closing conditions.
"We are pleased to announce what we believe is the largest debt financing of any publicly-traded MSO to date," said Joseph Bayern, Chief Executive Officer of Curaleaf. "This offering will allow us to refinance our existing debt at a materially lower interest rate and provides us with additional financial flexibility to execute our strategic growth initiatives. While this initial offering provides more than enough liquidity to refinance our existing debt and meet current needs, the new Indenture provides us a new degree of flexibility to raise debt financing to ensure we have ample liquidity to meet our needs now and into the future."
Seaport Global Securities LLC and Canaccord Genuity Corp. (the "Agents") acted as placement agents for the Notes in the United States and Canada, respectively.
The Notes are being offered on a private placement basis in certain provinces and territories of Canada pursuant to applicable exemptions from the prospectus requirements of Canadian securities laws. The Notes may also be sold in the United States to or for the account or benefit of "U.S. persons" (as defined in the United States Securities Act of 1933, as amended (the "U.S. Securities Act")), on a private placement basis to "qualified institutional buyers" and "accredited investors" pursuant to an exemption from the registration requirements of the U.S. Securities Act, and in such jurisdictions outside of Canada and the United States as may be agreed upon by the Agents and the Company, in each case in accordance with applicable laws. The Notes to be issued will be subject to a customary four-month hold period under Canadian securities laws.
No securities regulatory authority has either approved or disapproved of the contents of this news release. The Notes have not been and will not be registered under the U.S. Securities Act or any state securities laws. Accordingly, the Notes may not be offered or sold within the United States or to or for the account or benefit of "U.S. persons" unless registered under the U.S. Securities Act and applicable state securities laws or pursuant to exemptions from the registration requirements of the U.S. Securities Act and applicable state securities laws. This news release does not constitute an offer to sell or a solicitation of an offer to buy any securities of the Company in any jurisdiction in which such offer, solicitation or sale would be unlawful.
About Curaleaf Holdings
Curaleaf Holdings, Inc. (CSE: CURA) (OTCQX: CURLF) ("Curaleaf") is a leading international provider of consumer products in cannabis with a mission to improve lives by providing clarity around cannabis and confidence around consumption. As a high-growth cannabis company known for quality, expertise and reliability, the Company and its brands, including Curaleaf and Select, provide industry-leading service, product selection and accessibility across the medical and adult-use markets. In the United States, Curaleaf currently operates in 23 states with 113 dispensaries, 25 cultivation sites, and employs over 5,200 team members. Curaleaf International is the largest vertically integrated cannabis company in Europe with a unique supply and distribution network throughout the European market, bringing together pioneering science and research with cutting-edge cultivation, extraction and production. Curaleaf is listed on the Canadian Securities Exchange under the symbol CURA and trades on the OTCQX market under the symbol CURLF. For more information, please visit https://ir.curaleaf.com.
Curaleaf IR Twitter Account: https://twitter.com/Curaleaf_IR
Investor Toolkit: https://ir.curaleaf.com/investor-toolkit
Investor Relations Website: https://ir.curaleaf.com/
Forward Looking Statements
This media advisory contains forward–looking statements and forward–looking information within the meaning of applicable securities laws. These statements relate to future events or future performance. All statements other than statements of historical fact may be forward–looking statements or information. Generally, forward-looking statements and information may be identified by the use of forward-looking terminology such as "plans", "expects", "proposed", "is expected", "intends", "anticipates", or "believes", or variations of such words and phrases, or by the use of words or phrases which state that certain actions, events or results may, could, would, or might occur or be achieved. More particularly and without limitation, this news release contains forward–looking statements and information concerning the intended use of the net proceeds from the Offering. Such forward-looking statements and information reflect management's current beliefs and are based on assumptions made by and information currently available to the company with respect to the matter described in this new release. Forward-looking statements involve risks and uncertainties, which are based on current expectations as of the date of this release and subject to known and unknown risks and uncertainties that could cause actual results to differ materially from those expressed or implied by such statements. Additional information about these assumptions and risks and uncertainties is contained under "Risk Factors and Uncertainties" in the Company's latest annual information form filed?April 28, 2021, which is available under the Company's SEDAR profile at?http://www.sedar.com, and in other filings that the Company has made and may make with applicable securities authorities in the future. Forward-looking statements contained herein are made only as to the date of this press release and we undertake no obligation to update or revise any forward-looking statements whether as a result of new information, future events or otherwise, except as required by law. We caution investors not to place considerable reliance on the forward-looking statements contained in this press release. The Canadian Securities Exchange has not reviewed, approved or disapproved the content of this news release.
Investor Contact:
Curaleaf Holdings, Inc.
Carlos Madrazo, SVP Head of IR & Capital Markets
IR@curaleaf.com
Media Contact:
Curaleaf Holdings, Inc.
Tracy Brady, VP Corporate Communications
Media@curaleaf.com
SOURCE Curaleaf Holdings, Inc.
When cannabis is taken off schedule 1 and put as a commodity where it belongs the industry will follow a normal path. It looks like there may be some movement. Deschedule, it was bogus to make it illegal in the first place and let the folks out of jail and lets start enjoying the new booze. The one that heals your liver instead of frying it.
https://www.marijuanamoment.net/white-house-pressed-to-mediate-marijuana-finger-pointing-between-dea-and-hhs/
I’m still holding the top 3 MSO’s. Our time will come, just be patient.
While it’s against ones nature to purchase more of a stock after significant loses now is a better time than 6 months ago. Same dynamics are in play.
Wouldn't go that far. CURA has lots of assets. I had to dump my cura holding for tax losses. Bought some TRU to stay in cannabis. I'll get back in CURA after my 30 days are up. I still think they're gonna crush it.
Trulieve might buy out curaleaf in the future is a better bet than 20-60.
well someones got to Be the dominate player. that's why Trulieve is here.
Disappointed w/ PPS Movement
Hopefully, entire sector will pop up soon.
Really dependent on US legislation.
Could be, we will revisit this in a few years.
Could be. Don't forget to factor in NY, NJ, Tryke, and EU revs for cura as well.
I think 2B was WAY to much for harvest. That one is gonna sting for at least 2 years.
Still think cura is positioned best with more revenue and such. We'll see who doubles first.
Think cura will get to $20 before tru to $60.
Not to mention Boris owns almost half the shares that he'll NEVER sell anywhere or anytime before 50-100b MC. So, actual float is half the o/s and similar or less than tru. GL
Just saying Trulieve could be ahead on 4th quarter with Trulieve reporting earnings with full quarter of Harvest revenues.
Well...according to the 10q and their own website it was 224m. I didn't say double. I said 50% more. 50% of 224m is 112m more in rev.
https://www.sec.gov/ix?doc=/Archives/edgar/data/1754195/000095017021004442/tcnnf-20210930.htm
https://investors.trulieve.com/investors/
I'm not sure where your getting your info but there is no way Curaleaf has double the revenues especially profits than Trulieve and Harvest now combined. Curaleaf has 113 dispensaries and Trulieve has 162
3rd Quarter 2021 Revenues
Curaleaf 317,125,000
Trulieve 316,000,000
Come 4th quarter earnings Trulieve will be the largest MSO in the USA both in size and profits.
I'm still holding Curaleaf for now but if I see them cranking up the dilution like ACB I'll jump ship.
That's nice. I'm staying put. $CURLF has 3x more assets and 50% higher revenue. Sure largest army doesn't always win. But, if you know how to position your pieces properly chances are you CAN'T lose. Quite sure Boris and Joe are plenty capable at playing chess. Cause this isn't checkers...
Not that it's a race cause market is large enough for everyone. I'll say CURA gets to $20 before tru gets to $60. At current MC CURA only 30% larger than tru. Yet 3x more assets and 50% higher revenue. STRONG BUY with CURA and maybe just hold for tru going by that comparison. GL, Happy Thanksgiving
i've sold curlf. added it all into Tru.
Thank you for sharing this. I am good with what they are doing with growth. Very disappointed that he is calling protection for banks and hedge funds “social equity”! The reason Schumer is tying the money to freeing the prisoners who are pioneers of this industry to the ability for money flow is exactly this. Wall street wants to sell weed freely while there are people in jail today because they had a joint in their pocket. They want to start a super pac to lobby for the money when there are people who have a record for pot and they can not get a job or travel. Free the people who made this industry first, expunge the records of nonviolent cannabis “crimes” before you give the weed monopoly to the banksters. Enough of the rich guys and their hypocrisy. Just do the right thing. There is enough for everybody. If they allow safe banking before freeing the gardeners the gardeners will never get out. The people who started the industry will be shut out because you can not get a loan if you have a record. How much misery are you willing to make your neighbour suffer for you to have an extra dollar? Send Boris an email. Tell him to get his super pac to lobby for the freedom of the people AND the money. He can be a true hero not just another stuffed shirt stuffing his pockets at other’s expense. There is enough for everybody!
Thats scary, ACB has gone no where in 5 years. I guess I will quit putting more money in this one and put more of it in Cresco and Green Thumb. Already pretty well loaded up on Trulieve from my Harvest shares that converted.
Morgan Stanley can use it as a write off next month for taking the risk and mj being one of the only sectors red YTD. Nothing to worry about 1 billion shares approaching sooner than later vs the competitors producing ALMOST same amount yearly will have less than half the shares. I personally love all the msos!
Great interview with Boris (founder of Curaleaf) and others in re: Curaleaf.. Jason, a/k/a Wolf of Wall Street, is a very bright guy and expert in the space as well.
Here is the spaces from this week that @mayortoby and I did with @Boris_Jordan & @HammanShares special thx to @donkstriker for recording it u legend! $curlf $vrnof $gtbif $tcnnf $crlbf $trssf $msos https://t.co/NcIqZAHfjJ
— Jason Spatafora (@WolfOfWeedST) November 21, 2021
I see the same bloat here that I did in canadian LPs I have a small position just so I can get in on any pop on the news. Biden (and by default the democratic party) have been a great disappointment. Bernie would have had cannabis legal in the first hundred days. People can get their information from other sources now but they still buy the lie. So sad
In 3 months of Q3 the OS increased just under 2m. So, about 60 trading days would equal 30k shares per day. Hardly anything worth worrying about.
Shares Outstanding
As of September 30, 2021, and June 30, 2021, the Company's weighted average shares outstanding amounted to 703,545,262 and 701,668,932 shares, respectively.
https://ir.curaleaf.com/2021-11-08-Curaleaf-Reports-Third-Quarter-2021-Results
LOL, written by some motley FOOL Dbag...
FYI, Goldman Sachs double their position on TLRY 2 weeks ago. We ALL know $CURLF has a better business than they do. You know when they uplist gonna Triple sp in less than 1 year.
This is about the broader market for cannabis and how it will be affected by the legalization that finally passes. I much prefer to see Schumer’s bill pass since he is interested in having people succeed and not having the entire market taken over by the corporations that are already too big. If the safe or more acts are passed you are handing the industry to altria, and anhauser busch. This is the only thing that will stop the abuse of the past and make a healthier system going forward. The question is…. How brainwashed is the american public? Will they vote against their own best interests (again) because they have fallen for the propaganda? The instant banks and big business can freely deal in cannabis, any thought for those living the horror the war on drugs has inflicted will be out the window. “We just need to get banking done” is the way the rich stay rich. They care about money not people.
I’ve always compared curaleaf to acb. Same aggressive acquisition strategies while the hype is in paying inflated prices and diluting the shareholder.
Yep big trouble. So what kind of trouble are the Canadian companies in? Crash, Burned and in ashes?
Boris is no rookie. Pretty sure he knows what he's doing. I'm thinking they have all their assets in place now. NY, NJ coming around and with Tyke added figure they probably won't be making any real big deals for a bit. Just let the revenues come in.
Of course SAFE will just allow them to take other forms of payment and delete some expenses from having to always transport cash, etc...
But, what SAFE will also do is allow uplisting and large institutions in the door.
Net income -56.92M 509.19%
Diluted EPS - -
Net profit margin -17.95% 250.59%
Are they trying to expand faster than they should have?
Curaleaf Holdings, Inc. (OTCQX: CURLF) is buying western state operator Tryke Companies known for its Reef Dispensaries in a deal valued at approximately $286 million. The acquisition is expected to close in the second half of 2021. Curaleaf said it will be immediately accretive. Tryke is expected to deliver nearly $110 million in full year 2021 revenue.
Watch --->>> Marijuana Money November 12, 2021
I agree! Monday Republicans file their bill finally! So just need Democrats n Republicans to work together and finally unleash this industry
They must be testing some REAL potent shit and are still high as a kite. NM, that's the MM and day traders that are still messing around with this. With SAFE coming very soon and removal from sched 1 I wouldn't try timing(trading) this right now. Could just fly away on you and chasing isn't much fun.
We almost went red today? When gti did 16% what’s going on with Cura the biggest mso in Usa?
Market Cap Market Cap
5,704,551,630
11/10/2021
Authorized Shares
Unlimited
11/03/2021
Outstanding Shares
613,366,267
11/03/2021
Restricted
211,196,342
11/03/2021
Unrestricted
402,169,925
11/03/2021
Held at DTC
87,115,675
11/03/2021
Float
462,786,564
07/22/2021
Big manipulation in the US MSO names. Also broad markets looking choppy. Will take another entry if we test the recent lows.
They owe more than they have and because of the high taxes in the US every quarter is a loss no matter how much product they sell. That is a problem when you are trying to run a business. If every person who owns an american cannabis stock wrote their congress person or senator they could move the needle. Other than that, the US will whither while the rest of the world builds businesses and supports their success.
Followers
|
163
|
Posters
|
|
Posts (Today)
|
0
|
Posts (Total)
|
3905
|
Created
|
10/29/18
|
Type
|
Free
|
Moderators |
info@curaleaf.com
(781) 451-0150
301 Edgewater Place
Suite 405
Wakefield, MA 01880
Christine Rigby, SVP, Investor Relations
PH: (781) 451-0150
Info@curaleaf.com
Investor Contact: KCSA Strategic Communications
Valter Pinto, Managing Director
PH: (212) 896-1260
IR@curaleaf.com
Strategy is the roadmap towards execution. The ideas generated by creativity are meaningless without a focused direction.
Strategy is at the core of who we are. Without a plan of action, ideas would never see the light of day.
A strategy that aligns with your business objectives and communications goals means you’re in control of every conversation and outcome.
Curaleaf Hemp products include:
Volume | |
Day Range: | |
Bid Price | |
Ask Price | |
Last Trade Time: |